NASDAQ:BASI - Nasdaq -
16.44
+1.42 (+9.45%)
The current stock price of BASI is 16.44 null. In the past month the price increased by 4.51%. In the past year, price increased by 415.36%.
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.
Bioanalytical Syst
2701 KENT AVENUE
WEST LAFAYETTE IN 47906
CEO: Robert W. Leasure Jr.
Phone: 765-463-4527
The current stock price of BASI is 16.44 null. The price increased by 9.45% in the last trading session.
The exchange symbol of Bioanalytical Syst is BASI and it is listed on the Nasdaq exchange.
BASI stock is listed on the Nasdaq exchange.
Bioanalytical Syst (BASI) has a market capitalization of 182.99M null. This makes BASI a Micro Cap stock.
Bioanalytical Syst (BASI) has a support level at 14.38. Check the full technical report for a detailed analysis of BASI support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BASI does not pay a dividend.
Bioanalytical Syst (BASI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).
ChartMill assigns a technical rating of 9 / 10 to BASI. When comparing the yearly performance of all stocks, BASI is one of the better performing stocks in the market, outperforming 96.63% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to BASI. Both the profitability and financial health of BASI have multiple concerns.
Over the last trailing twelve months BASI reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -190.91% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -5.54% | ||
ROA | -5.77% | ||
ROE | N/A | ||
Debt/Equity | 2.31 |
ChartMill assigns a Buy % Consensus number of 80% to BASI. The Buy consensus is the average rating of analysts ratings from 1 analysts.